Nov 04, 2019
Former FDA and Regulatory Experts from Lachman Consultants, Inc., to Serve as Panelists at AAM GRx & Biosimilars Meeting
Oct 25, 2019
NanoScan Offers Breakthrough Nanoparticulate Contrast Agent for Sale
May 31, 2019
Two Day FDA Drug Approval Process Seminar: FDA Requirements for Submission of NDAs, ANDAs and 505(b)(2) - London, United Kingdom - September 19-20, 2019
Apr 11, 2019
Takara Bio submits Drug Master File to US FDA for RetroNectin® GMP grade (liquid format)
Mar 28, 2019
Drug Master Files (DMF) Course: Translating FDA Guidances into Usable Documentation (San Diego, United States - July 18th-19th, 2019)
Sep 27, 2018
Two Day Common Technical Document Course - Regulatory and Technical Requirements for CMC Management (London, United Kingdom - December 4-5, 2018)
Sep 17, 2018
Two Day Seminar: eCTD Submissions of IND and NDA/BLA to the US FDA, EU and Canada (Newark, NJ, United States - November 8th-9th, 2018)
May 10, 2018
Two Day Workshop: eCTD Submissions of IND and NDA/BLA to the US FDA, EU and Canada - Burlingame CA, United States - May 31st, 2018 June 1st, 2018
Jan 17, 2018
2 Day Course: The Use of Drug Master Files & Quality Agreements: Understanding and Meeting your Regulatory and Processing Responsibilities (Philidelphia, PA, United States - April 12-13, 2018) - ResearchAndMarkets.com
Jan 08, 2018
FDA Removes Expired Drug Establishment Registrations and Uncertified Listings from its Database
Dec 19, 2017
EAS Consulting Group, LLC Announces New Independent Advisor for Pharmaceutical Submissions, Albert Yehaskel
Nov 13, 2017
eCTD Submissions of IND and NDA/BLA to the US FDA, EU and Canada: 2-Day Workshop by Ex-FDA Official (Orlando, FL, United States - February 1-2, 2018) - Research and Markets
Nov 08, 2017
Statement from FDA Commissioner Scott Gottlieb, M.D. on new steps to improve FDA review of shared Risk Evaluation and Mitigation Strategies to improve generic drug access